May 20, 2026
3 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
FORT LAUDERDALE, Fla. — Dopamine signaling may play a role in age-related macular degeneration, as shown through a possible association between dopamine antagonists and disease progression, according to a presenter. “Dopamine is not just a neurotransmitter in the brain; it is also produced in the retina, and it plays important roles in light adaptation, cellular signaling and vascular
May 20, 2026
3 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Find the latest Retina and Vitreous news articles, videos, podcasts, and meeting coverage from medical experts and key opinion…

DENVER — Three biomarkers of age-related macular degeneration lesion growth were significantly reduced over 1 year in patients…

DENVER — A real-world analysis showed increased rates of undertreatment and attrition with anti-VEGF injections in patients with…

DENVER — Glaucoma and hypertension were both linked with worsened cognitive performance, according to a poster presentation at…

Studies show that GLP-1 receptor agonists have significant potential for treating glaucoma, diabetic retinopathy and other eye…

Several CVD subtypes including high and low BP, arrhythmia disorders and cerebral infarction, were significantly associated with…